NCT05208450Enrolling by invitation
Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks
Source: ClinicalTrials.gov · Last updated 2 Jun 2026
Brief summary (registry, in English)
To use practice facilitation (PF) + community health worker (CHW) facilitation as a practical and sustainable implementation strategy to support the implementation and evaluation of three multi-level evidence-based interventions \[nurse case management (NCM), remote blood pressure monitoring (RBPM), and social determinants of health (SDOH) support\] delivered as an integrated community-clinic linkage model \[Practice support And Community Engagement (PACE) to address patient-, physician-, health system-, and community-level barriers to hypertension (HTN) control in Blacks across 25 primary practices within NYU Langone Health in New York City (NYC) and, in partnership with an established Community-Clinic-Academic Advisory Board and HealthFirst (NYC's largest Medicaid payer). The goal for the UH3 Implementation Phase (Years 4-7, Intervention) is to evaluate a stepped-wedge cluster RCT of 25 primary care practices in Black patients with uncontrolled hypertension (HTN)
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- First submitted
- 11 Jan 2022
- Start date
- 12 Jun 2025
- Primary completion date
- 31 Aug 2027
- Lead sponsor
- NYU Langone Health
- Diseases
- High blood pressure
- NCT number
- NCT05208450
What you commit to
- Study type: Interventional
- Planned participants: 500
- From 12 Jun 2025 to the primary completion date, 31 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- participate in other hypertension-related clinical trials
- have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR)
- NYULH Primary care provider (MD/DO, NP), Clinical Director, Site Administrator, Medical Assistant, or administrative staff employed at the participating practices and interacts with at least five patients with a diagnosis of hypertension; or
Other
- Patients will be ineligible for the study if they:
- are deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks)
- plan to discontinue care at the site within the next 12 months; or
- are pregnant or planning to become pregnant in the next 12 months
- IMPLEMENTATION EVALUATION
- NYULH Nurse case manager within centralized service; or
- Staff and leadership of community- and faith-based organizations serving the Black community; or
- NYULH Organizational leadership; or
- NYULH Project Staff: Community Health Workers/CHW Supervisor/Practice Facilitators; and
- Able and willing to provide consent
- 1\. Refusal to participate
Who the study is looking for
- Patients are eligible if he/she:
- identifies as Black (through EHR code or self-report)
- is 18+ years of age
- has a diagnosis of HTN (identified by ICD-10 codes for HTN)
- prescribed an antihypertensive medication(s)
- has a clinic BP \> 130/80 mmHg
Criteria the registry did not label
- UH3 IMPLEMENTATION PHASE (Years 4 - 7): INTERVENTION
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NYU Langone Health Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.